Daily News | Pharmaceutical sales collapse

We are continuing to analyze this first week of the year today, with plenty of new and exciting opportunities out there for the discerning trader. Of course, this is the place to find all the data you need to make your mark today on the market, so stick with us! We start this Tuesday with the euro. From Friday to Monday, the currency fell from $1.0554 to $1.0483. This news comes to us as Eurozone factories are heading into 2017 with solid footing, after ramping up activity quicker than in the last half a decade in December. IHS Markit’s final 2016 manufacturing PMI registered 54.9 in that month, its highest since April 2011. This might continue this year, as a new orders sub-index peaked at 55.9, although companies did raise prices at the fastest rate in over five years. Now, let us look at the US dollar. In the same period, the USD rose from €0.9230 to €0.9539. This news comes to us as new data shows that last year was a disappointing one for pharmaceutical sales. This could indicate that the pharmaceutical industry may be returning to more standard productivity levels, after a spike in 2014 and 2015. We will continue to monitor these situations in the future, so be sure to follow us daily!

Daily News | Change your fortune this year!

To really make a change this year to your trading habits, we suggest you check out the broker 24option. In our 24option Withdrawal Review, we look at all the ways you can transfer your money around. The range of possibilities the company offers, from bank wire transfers and electronic payments to credit cards pleasantly surprised us. Withdrawal can be done at any time, but your personal information has to be verified first. As far as safety is concerned, 24option has an impeccable record and are regulated by CySEC, the EU’s primary regulatory body for binary options. For more information, check out the full article!

Author's overall rating:
Author: Max Rothstein

BinaryOptionsTrading-Review.com has taken reasonable measures to ensure the accuracy of the information in the website, however, does not guarantee it. The data exhibited in this website is not necessarily always real-time or completely accurate; this includes market analysis, forecasts, signals, assets’ price quotes and charts. Readers should not treat any opinion expressed by the authors of BinaryOptionsTrading-Review.com as a specific inducement to make a particular trade or follow a particular strategy, but only as an expression of their current opinion. The risks involved in trading binary options are high and may not be suitable for all traders. BinaryOptionsTrading-Review.com doesn't retain responsibility for any losses readers might face as a result of using the information presented in this website. This website is owned by Next Media Corp.
In accordance with FTC guidelines, BinaryOptionsTrading-Review.com has financial relationships with some of the products and services mentioned on this website. BinaryOptionsTrading-Review.com may be compensated if consumers choose to click links in our content and ultimately sign up for mentioned products.
Binary options are not promoted or sold to retail EEA traders. If you are not a professional client, please leave this page.